What We're Reading: Page 148
Industry reads hand-picked by our editors
Oct 08, 2021
Oct 07, 2021
-
The New York Times
First Malaria Vaccine Approved by W.H.O.
-
STAT
Amgen's Lumakras disappoints in combination with other drugs
-
Roll Call
FDA’s internal turmoil could impact boosters, shots for kids
-
MIT Technology Review
Tech millionaire Steve Kirsch went from covid trial funder to misinformation superspreader
Oct 06, 2021
Oct 05, 2021
-
Associated Press
Henrietta Lacks estate sues company using her 'stolen' cells
-
ProPublica
McKinsey Never Told the FDA It Was Working for Opioid Makers While Also Working for the Agency
-
Reuters
A year after COVID vaccine waiver proposal, WTO talks are deadlocked
-
C&EN
Exo Therapeutics raises $78 million to target enzyme exosites with small molecules
Oct 04, 2021
-
Nature
Medicine Nobel goes to scientists who discovered biology of senses
-
The Wall Street Journal
Covid-19 Vaccine Makers Say There Are Enough Doses for Everyone. Poor Countries Are Still Waiting for Shots.
-
Axios
Pfizer loses case to subsidize heart drug for Medicare patients
-
STAT
Inside the downfall of longevity crusader Aubrey de Grey
Oct 01, 2021
-
The Wall Street Journal
Deaths Raise Safety Concerns Around Gene Therapy
-
Business Insider
A COVID-19 pill could soon fill a gap in our pandemic response that vaccines can’t overcome
-
Pink Sheet
Premature PRV: US FDA Mistakenly Announces Voucher Award For Enzyvant Ahead Of Approval
-
STAT
Mapping proteins could offer a clearer view of what’s driving cancer
Previous
